ASX - By Stock
|
4DX |
Re:
Ann: Release of restricted securities from escrow
|
|
wop
|
2 |
1.1K |
5 |
08/08/22 |
08/08/22 |
ASX - By Stock
|
2
|
1.1K
|
5
|
|
ASX - By Stock
|
4DX |
Re:
VA Deal In US
|
|
wop
|
53 |
23K |
3 |
05/08/22 |
05/08/22 |
ASX - By Stock
|
53
|
23K
|
3
|
|
ASX - By Stock
|
CSL |
Re:
CSL - $300 and beyond
|
|
wop
|
91 |
50K |
2 |
04/08/22 |
04/08/22 |
ASX - By Stock
|
91
|
50K
|
2
|
|
ASX - By Stock
|
RMD |
Re:
Ann: RMD to Report Third Quarter Fiscal 2022 Results
|
|
wop
|
28 |
23K |
1 |
04/08/22 |
04/08/22 |
ASX - By Stock
|
28
|
23K
|
1
|
|
ASX - By Stock
|
CSL |
Re:
CSL - $300 and beyond
|
|
wop
|
91 |
50K |
3 |
04/08/22 |
04/08/22 |
ASX - By Stock
|
91
|
50K
|
3
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
wop
|
2.5K |
1.1M |
9 |
03/08/22 |
03/08/22 |
ASX - By Stock
|
2.5K
|
1.1M
|
9
|
|
ASX - By Stock
|
4DX |
Re:
VA Deal In US
|
|
wop
|
53 |
23K |
7 |
03/08/22 |
03/08/22 |
ASX - By Stock
|
53
|
23K
|
7
|
|
ASX - By Stock
|
4DX |
Re:
VA Deal In US
|
|
wop
|
53 |
23K |
7 |
03/08/22 |
03/08/22 |
ASX - By Stock
|
53
|
23K
|
7
|
|
ASX - By Stock
|
4DX |
Re:
VA Deal In US
|
|
wop
|
53 |
23K |
8 |
02/08/22 |
02/08/22 |
ASX - By Stock
|
53
|
23K
|
8
|
|
ASX - By Stock
|
4DX |
Re:
VA Deal In US
|
|
wop
|
53 |
23K |
9 |
02/08/22 |
02/08/22 |
ASX - By Stock
|
53
|
23K
|
9
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Quarterly Activity Report and Appendix 4C for Q4 FY2022
|
|
wop
|
32 |
11K |
5 |
29/07/22 |
29/07/22 |
ASX - By Stock
|
32
|
11K
|
5
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
wop
|
2.5K |
1.1M |
6 |
29/07/22 |
29/07/22 |
ASX - By Stock
|
2.5K
|
1.1M
|
6
|
|
ASX - By Stock
|
MAQ |
Re:
Good news, bad news
|
|
wop
|
545 |
252K |
2 |
29/07/22 |
29/07/22 |
ASX - By Stock
|
545
|
252K
|
2
|
|
ASX - By Stock
|
PWH |
Re:
Latest Interview With Kee's
|
|
wop
|
2 |
1.1K |
2 |
28/07/22 |
28/07/22 |
ASX - By Stock
|
2
|
1.1K
|
2
|
|
ASX - By Stock
|
PWH |
Latest Interview With Kee's
|
|
wop
|
2 |
1.1K |
6 |
27/07/22 |
27/07/22 |
ASX - By Stock
|
2
|
1.1K
|
6
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Quarterly Activity Report and Appendix 4C for Q4 FY2022
|
|
wop
|
32 |
11K |
11 |
25/07/22 |
25/07/22 |
ASX - By Stock
|
32
|
11K
|
11
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
wop
|
2.5K |
1.1M |
8 |
22/07/22 |
22/07/22 |
ASX - By Stock
|
2.5K
|
1.1M
|
8
|
|
ASX - By Stock
|
4DX |
Re:
Andreas Latest Interview
|
|
wop
|
9 |
4.0K |
11 |
21/07/22 |
21/07/22 |
ASX - By Stock
|
9
|
4.0K
|
11
|
|
ASX - By Stock
|
4DX |
Andreas Latest Interview
|
|
wop
|
9 |
4.0K |
14 |
20/07/22 |
20/07/22 |
ASX - By Stock
|
9
|
4.0K
|
14
|
|
ASX - By Stock
|
RHY |
Re:
Ann: RHY Advances Platform Expansion with Other Cancers
|
|
wop
|
24 |
12K |
12 |
19/07/22 |
19/07/22 |
ASX - By Stock
|
24
|
12K
|
12
|
|
ASX - By Stock
|
RHY |
Re:
News: RHY Rhythm Biosciences Files With TGA To List Colostat On Register Of Therapeutic Goods
|
|
wop
|
67 |
33K |
8 |
18/07/22 |
18/07/22 |
ASX - By Stock
|
67
|
33K
|
8
|
|
ASX - By Stock
|
RHY |
Re:
News: RHY Rhythm Biosciences Files With TGA To List Colostat On Register Of Therapeutic Goods
|
|
wop
|
67 |
33K |
7 |
18/07/22 |
18/07/22 |
ASX - By Stock
|
67
|
33K
|
7
|
|
ASX - By Stock
|
PWH |
Full Results FY22
|
|
wop
|
0 |
456 |
2 |
14/07/22 |
14/07/22 |
ASX - By Stock
|
0
|
456
|
2
|
|
ASX - By Stock
|
4DX |
Re:
VA Deal In US
|
|
wop
|
53 |
23K |
5 |
14/07/22 |
14/07/22 |
ASX - By Stock
|
53
|
23K
|
5
|
|
ASX - By Stock
|
RHY |
Re:
News: RHY Rhythm Biosciences Files With TGA To List Colostat On Register Of Therapeutic Goods
|
|
wop
|
67 |
33K |
4 |
14/07/22 |
14/07/22 |
ASX - By Stock
|
67
|
33K
|
4
|
|
ASX - By Stock
|
RHY |
Re:
News: RHY Rhythm Biosciences Files With TGA To List Colostat On Register Of Therapeutic Goods
|
|
wop
|
67 |
33K |
4 |
14/07/22 |
14/07/22 |
ASX - By Stock
|
67
|
33K
|
4
|
|
ASX - By Stock
|
RHY |
Re:
News: RHY Rhythm Biosciences Files With TGA To List Colostat On Register Of Therapeutic Goods
|
|
wop
|
67 |
33K |
4 |
13/07/22 |
13/07/22 |
ASX - By Stock
|
67
|
33K
|
4
|
|
ASX - By Stock
|
DEG |
Re:
Ann: AMP:Update on Collimate Capital domestic business
|
|
wop
|
56 |
25K |
8 |
06/07/22 |
06/07/22 |
ASX - By Stock
|
56
|
25K
|
8
|
|
ASX - By Stock
|
4DX |
VA Deal In US
|
|
wop
|
53 |
23K |
15 |
05/07/22 |
05/07/22 |
ASX - By Stock
|
53
|
23K
|
15
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DMedical secures national contract with I-MED
|
|
wop
|
55 |
24K |
5 |
05/07/22 |
05/07/22 |
ASX - By Stock
|
55
|
24K
|
5
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DMedical secures national contract with I-MED
|
|
wop
|
55 |
24K |
4 |
04/07/22 |
04/07/22 |
ASX - By Stock
|
55
|
24K
|
4
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DMedical secures national contract with I-MED
|
|
wop
|
55 |
24K |
6 |
04/07/22 |
04/07/22 |
ASX - By Stock
|
55
|
24K
|
6
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Scheme Update
|
|
wop
|
132 |
46K |
48 |
02/07/22 |
02/07/22 |
ASX - By Stock
|
132
|
46K
|
48
|
|
ASX - By Stock
|
RHY |
Re:
News: RHY Rhythm Biosciences Files With TGA To List Colostat On Register Of Therapeutic Goods
|
|
wop
|
67 |
33K |
7 |
01/07/22 |
01/07/22 |
ASX - By Stock
|
67
|
33K
|
7
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DMedical secures national contract with I-MED
|
|
wop
|
55 |
24K |
6 |
01/07/22 |
01/07/22 |
ASX - By Stock
|
55
|
24K
|
6
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DMedical secures national contract with I-MED
|
|
wop
|
55 |
24K |
6 |
29/06/22 |
29/06/22 |
ASX - By Stock
|
55
|
24K
|
6
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DMedical secures national contract with I-MED
|
|
wop
|
55 |
24K |
10 |
29/06/22 |
29/06/22 |
ASX - By Stock
|
55
|
24K
|
10
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DMedical appoints experienced MedTech CFO
|
|
wop
|
4 |
2.0K |
8 |
24/06/22 |
24/06/22 |
ASX - By Stock
|
4
|
2.0K
|
8
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
wop
|
2.5K |
1.1M |
1 |
13/05/22 |
13/05/22 |
ASX - By Stock
|
2.5K
|
1.1M
|
1
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
wop
|
2.5K |
1.1M |
4 |
12/05/22 |
12/05/22 |
ASX - By Stock
|
2.5K
|
1.1M
|
4
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
wop
|
2.5K |
1.1M |
2 |
11/05/22 |
11/05/22 |
ASX - By Stock
|
2.5K
|
1.1M
|
2
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
wop
|
2.5K |
1.1M |
4 |
11/05/22 |
11/05/22 |
ASX - By Stock
|
2.5K
|
1.1M
|
4
|
|
ASX - By Stock
|
RHY |
Updated Analysts Report Just Out
|
|
wop
|
2 |
1.7K |
9 |
26/04/22 |
26/04/22 |
ASX - By Stock
|
2
|
1.7K
|
9
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
wop
|
2.5K |
1.1M |
3 |
19/04/22 |
19/04/22 |
ASX - By Stock
|
2.5K
|
1.1M
|
3
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Rhythm Biosciences - Investor Presentation
|
|
wop
|
36 |
17K |
0 |
12/04/22 |
12/04/22 |
ASX - By Stock
|
36
|
17K
|
0
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Study 7 Confirms ColoSTAT Meets Primary Endpoint
|
|
wop
|
17 |
6.7K |
7 |
04/04/22 |
04/04/22 |
ASX - By Stock
|
17
|
6.7K
|
7
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DX purpose-built 4D lung scanner for its XV Technology
|
|
wop
|
19 |
12K |
10 |
28/03/22 |
28/03/22 |
ASX - By Stock
|
19
|
12K
|
10
|
|
ASX - By Stock
|
RAP |
Re:
What's it worth
|
|
wop
|
26 |
8.4K |
5 |
26/03/22 |
26/03/22 |
ASX - By Stock
|
26
|
8.4K
|
5
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Appendix 3Y - AF
|
|
wop
|
1 |
1.0K |
7 |
25/03/22 |
25/03/22 |
ASX - By Stock
|
1
|
1.0K
|
7
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DX purpose-built 4D lung scanner for its XV Technology
|
|
wop
|
19 |
12K |
12 |
25/03/22 |
25/03/22 |
ASX - By Stock
|
19
|
12K
|
12
|
|